Dose-dependent differential upregulation of CCN1/Cyr61 and CCN3/NOV by the gap junction protein connexin43 in glioma cells

Journal of Cellular Biochemistry

Volumn 103, Issue 6, 2008, Pages 1772-1782

  Wun, Chey Sin ^a   Bechberger, John F ^a   Rushlow, Walter J ^b   Naus, Christian C ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

CCN1; CCN3; Connexin 43; Gap junctions; Gliomas

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; CONNEXIN 43; CYSTEINE RICH PROTEIN 61; GAP JUNCTION PROTEIN;

ARTICLE; CELL GROWTH; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; DOSE RESPONSE; EXTRACELLULAR MATRIX; GLIOMA CELL; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

ANIMALS; BRAIN NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; CONNEXIN 43; GAP JUNCTIONS; GLIOMA; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; RATS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 41849112032     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21571     Document Type: Article

References (47)

1. Abramoff MD, Magelhaes PJ, Ram SJ. 2004. Image processing with ImageJ. Biophotonics Int 11:36-42.
2. Babic AM, Kireeva ML, Kolesnikova TV, Lau LF. 1998. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci U S A 95:6355-6360.
3. Bleau AM, Planque N, Perbal B. 2005. CCN proteins and cancer: Two to tango. Front Biosci 10:998-1009.
4. Brigstock DR. 2003. The CCN family: A new stimulus package. J Endocrinol 178:169-175.
5. Chien W, Kumagai T, Miller CW, Desmond JC, Frank JM, Said JW, Koeffler HP. 2004. Cyr61 suppresses growth of human endometrial cancer cells. J Biol Chem 279:53087-53096.
6. Chintala SK, Gokaslan ZL, Go Y, Sawaya R, Nicolson GL, Rao JS. 1996. Role of extracellular matrix proteins in regulation of human glioma cell invasion in vitro. Clin Exp Metastasis 14:358-366.
7. Chintala SK, Rao JK. 1996. Invasion of human glioma: Role of extracellular matrix proteins. Front Biosci 1:d324-d339.
8. Del Duca D, Werbowetski T, Del Maestro RF. 2004. Spheroid preparation from hanging drops: Characterization of a model of brain tumor invasion. J Neurooncol 67:295-303.
9. Demuth T, Berens ME. 2004. Molecular mechanisms of glioma cell migration and invasion. J Neurooncol 70:217-228.
10. Fu CT, Bechberger JF, Ozog MA, Perbal B, Naus CC. 2004. CCN3 (NOV) interacts with connexin43 in C6 glioma cells: Possible mechanism of connexin-mediated growth suppression. J Biol Chem 279:36943-36950.
11. Gellhaus A, Dong X, Propson S, Maass K, Klein-Hitpass L, Kibschull M, Traub O, Willecke K, Perbal B, Lye SJ, Winterhager E. 2004. Connexin43 interacts with NOV: A possible mechanism for negative regulation of cell growth in choriocarcinoma cells. J Biol Chem 279:36931-36942.
12. Grobben B, De Deyn PP, Siegers H. 2002. Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion. Cell Tissue Res 310:257-270.
13. Gupta N, Wang H, McLeod TL, Naus CC, Kyurkchiev S, Advani S, Yu J, Perbal B, Weichselbaum RR. 2001. Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV). Mol Pathol 54:293-299.
14. Herve JC, Bourmeyster N, Sarrouilhe D. 2004. Diversity in protein-protein interactions of connexins: Emerging roles. Biochim Biophys Acta 1662:22-41.
15. Huang RP, Fan Y, Hossain MZ, Peng A, Zeng ZL, Boynton AL. 1998. Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (cx43). Cancer Res 58:5089-5096.
16. Huang RP, Hossain MZ, Sehgal A, Boynton AL. 1999. Reduced connexin43 expression in high-grade human brain glioma cells. J Surg Oncol 70:21-24.
17. Iacobas DA, Iacobas S, Li WE, Zoidl G, Dermietzel R, Spray DC. 2005. Genes controlling multiple functional pathways are transcriptionally regulated in connexin43 null mouse heart. Physiol Genomics 20:211-223.
18. Kireeva ML, Mo FE, Yang GP, Lau LF. 1996. Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion. Mol Cell Biol 16:1326-1334.
19. Knott JC, Mahesparan R, Garcia-Cabrera I, Bolge Tysnes B, Edvardsen K, Ness GO, Mork S, Lund-Johansen M, Bjerkvig R. 1998. Stimulation of extracellular matrix components in the normal brain by invading glioma cells. Int J Cancer 75:864-872.
20. Latinkic BV, O'Brien TP, Lau LF. 1991. Promoter function and structure of the growth factor-inducible immediate early gene cyr61. Nucleic Acids Res 19:3261-3267.
21. Lin CG, Chen CC, Leu SJ, Grzeszkiewicz TM, Lau LF. 2005. Integrin-dependent functions of the angiogenic inducer NOV (CCN3): Implication in wound healing. J Biol Chem 280:8229-8237.
22. Lin CG, Leu SJ, Chen N, Tebeau CM, Lin SX, Yeung CY, Lau LF. 2003. CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family. J Biol Chem 278:24200-24208.
23. Manara MC, Perbal B, Benini S, Strammiello R, Cerisano V, Perdichizzi S, Serra M, Astolfi A, Bertoni F, Aland J, Yeger H, Picci P, Scotlandi K. 2002. The expression of ccn3(nov) gene in musculoskeletal tumors. Am J Pathol 160:849-859.
24. Mao AJ, Bechberger J, Lidington D, Galipeau J, Laird DW, Naus CC. 2000. Neuronal differentiation and growth control of neuro-2a cells after retroviral gene delivery of connexin43. J Biol Chem 275:34407-34414.
25. McLeod TL, Bechberger JF, Naus CC. 2001. Determination of a potential role of the CCN family of growth regulators in connexin43 transfected C6 glioma cells. Cell Commun Adhes 8:441-445.
26. Mesnil M. 2002. Connexins and cancer. Biol Cell 94:493-500.
27. Mesnil M, Crespin S, Avanzo JL, Zaidan-Dagli ML. 2005. Defective gap junctional intercellular communication in the carcinogenic process. Biochim Biophys Acta 1719:125-145.
28. Naus CC, Bond SL, Bechberger JF, Rushlow W. 2000. Identification of genes differentially expressed in C6 glioma cells transfected with connexin43. Brain Res Brain Res Rev 32:259-266.
29. Naus CC, Elisevich K, Zhu D, Belliveau DJ, Del Maestro RF. 1992. In vivo growth of C6 glioma cells transfected with connexin43 cDNA. Cancer Res 52:4208-4213.
30. Ohnishi T, Arita N, Hiraga S, Taki T, Izumoto S, Fukushima Y, Hayakawa T. 1997. Fibronectin-mediated cell migration promotes glioma cell invasion through chemokinetic activity. Clin Exp Metastasis 15:538-546.
31. Omori Y, Yamasaki H. 1998. Mutated connexin43 proteins inhibit rat glioma cell growth suppression mediated by wild-type connexin43 in a dominant-negative manner. Int J Cancer 78:446-453.
32. Pendurthi UR, Tran TT, Post M, Rao LV. 2005. Proteolysis of CCN1 by plasmin: Functional implications. Cancer Res 65:9705-9711.
33. Penes MC, Li X, Nagy JI. 2005. Expression of zonula occludens-1 (ZO-1) and the transcription factor ZO-1-associated nucleic acid-binding protein (ZONAB)-MsY3 in glial cells and colocalization at oligodendrocyte and astrocyte gap junctions in mouse brain. Eur J Neurosci 22:404-418.
34. Perbal B. 2004. CCN proteins: Multifunctional signalling regulators. Lancet 363:62-64.
35. Perbal B. 2006. NOV story: The way to CCN3. Cell Commun Signal 4:3.
36. Planque N, Long Li C, Saule S, Bleau AM, Perbal B. 2006. Nuclear addressing provides a clue for the transforming activity of amino-truncated CCN3 proteins. J Cell Biochem 99:105-116.
37. Rooprai HK, Vanmeter T, Panou C, Schnull S, Trillo-Pazos G, Davies D, Pilkington GJ. 1999. The role of integrin receptors in aspects of glioma invasion in vitro. Int J Dev Neurosci 17:613-623.
38. Scholz G, Martinerie C, Perbal B, Hanafusa H. 1996. Transcriptional down regulation of the nov proto-oncogene in fibroblasts transformed by p60v-src. Mol Cell Biol 16:481-486.
39. Soroceanu L, Manning TJ, Jr., Sontheimer H. 2001. Reduced expression of connexin-43 and functional gap junction coupling in human gliomas. Glia 33:107-117.
40. Suzuki SO, Iwaki T. 2005. Dynamic analysis of glioma cells: Looking into "movement phenotypes". Neuropathology 25:254-262.
41. Tong X, O'Kelly J, Xie D, Mori A, Lemp N, McKenna R, Miller CW, Koeffler HP. 2004. Cyr61 suppresses the growth of non-small-cell lung cancer cells via the beta-catenin-c-myc-p53 pathway. Oncogene 23:4847-4855.
42. Tong X, Xie D, O'Kelly J, Miller CW, Muller-Tidow C, Koeffler HP. 2001. Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer. J Biol Chem 276:47709-47714.
43. Xia Z, Pu P, Huang Q. 2001. Effect of transfected Cx43 gene on the gap junction intercellular communication and the human glioma cells proliferation. Zhonghua Zhong Liu Za Zhi 23:465-468.
44. Xie D, Yin D, Tong X, O'Kelly J, Mori A, Miller C, Black K, Gui D, Said JW, Koeffler HP. 2004. Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways. Cancer Res 64:1987-1996.
45. Zhang W, Nwagwu C, Le DM, Yong VW, Song H, Couldwell WT. 2003. Increased invasive capacity of connexin43-overexpressing malignant glioma cells. J Neurosurg 99:1039-1046.
46. Zhu D, Caveney S, Kidder GM, Naus CC. 1991. Transfection of C6 glioma cells with connexin 43 cDNA: Analysis of expression, intercellular coupling, and cell proliferation. Proc Natl Acad Sci U S A 88:1883-1887.
47. Zhu D, Kidder GM, Caveney S, Naus CC. 1992. Growth retardation in glioma cells cocultured with cells overexpressing a gap junction protein. Proc Natl Acad Sci U S A 89:10218-10221.